Tadalafil 5 mg Once Daily Improves Lower Urinary Tract Symptoms and Erectile Dysfunction: A Systematic Review and Meta‐analysis
LUTS: Lower Urinary Tract Symptoms · 2018-01 · 10 (1) · 84-92
DOI: 10.1111/luts.12144 ↗Kurz gefasst
Metaanalyse in der Zeitschrift LUTS: Lower Urinary Tract Symptoms, online erschienen am 05.11.2016. Verfasst von Yilin Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biochip Laboratory, Yantai Yuhuangding Hospital Affiliated to Medical College of Qingdao University, Yantai, China. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Objectives
We carried out a systematic review and meta‐analysis to assess tadalafil 5 mg once‐daily for the treatment of lower urinary tract symptoms ( LUTS ) and erectile dysfunction ( ED ).
Methods
A literature review was performed to identify all published randomized double‐blind, placebo‐controlled trials of tadalafil 5 mg once‐daily for the treatment of LUTS and ED . The search included the following databases: MEDLINE , EMBASE , and the Cochrane Controlled Trials Register. The reference lists of the retrieved studies were also investigated.
Results
Thirteen publications involving a total of 3973 patients were used in the analysis, including 13 RCTs that compared tadalafil 5 mg once‐daily with placebo. We found that tadalafil 5 mg once‐daily was effective in improving LUTS suggestive of BPH and treating ED over 12 weeks in our meta‐analysis. Total International Prostate Symptom Score ( IPSS ) ( SMD = − 2.02, 95% CI = − 2.52 to −1.53, P < 0.00001); Benign Prostatic Hyperplasia Impact Index ( BPH‐II ) ( SMD = −0.58, 95% CI = −0.84 to −0.33, P < 0.00001); International Index of Erectile Function‐erectile function ( IIEF ) domain (standardized mean difference [ SMD ] = 5.18, 95% confidence interval [ CI ] = 4.13–6.23, P < 0.00001) indicated that tadalafil 5 mg once‐daily was more effective than the placebo. Safety assessments included discontinuations due to adverse event (odds ratio ( OR ) = 1.79, 95% CI = 1.12–2.85, P = 0.01) indicated that tadalafil 5 mg once‐daily was well tolerated.
Conclusions
This meta‐analysis indicates that tadalafil 5 mg once‐daily to be an effective treatment for LUTS and ED with a low occurrence of side effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biochip Laboratory, Yantai Yuhuangding Hospital Affiliated to Medical College of Qingdao University, Yantai, China.
- Department of Urology, Yantai Yuhuangding Hospital Affiliated to Medical College of Qingdao University, Yantai, China.
Zitieren
APA
Wang, Y., Bao, Y., Liu, J., Duan, L., & Cui, Y. (2018). Tadalafil 5 mg Once Daily Improves Lower Urinary Tract Symptoms and Erectile Dysfunction: A Systematic Review and Meta‐analysis. LUTS: Lower Urinary Tract Symptoms, 10(1), 84-92. https://doi.org/10.1111/luts.12144
Vancouver
Wang Y, Bao Y, Liu J, Duan L, Cui Y. Tadalafil 5 mg Once Daily Improves Lower Urinary Tract Symptoms and Erectile Dysfunction: A Systematic Review and Meta‐analysis. LUTS: Lower Urinary Tract Symptoms. 2018;10(1):84-92. doi:10.1111/luts.12144
BibTeX
@article{Wang2018,
author = {Wang, Yilin and Bao, Yiping and Liu, Jie and Duan, Lijun and Cui, Yuanshan},
title = {Tadalafil 5 mg Once Daily Improves Lower Urinary Tract Symptoms and Erectile Dysfunction: A Systematic Review and Meta‐analysis},
journal = {LUTS: Lower Urinary Tract Symptoms},
year = {2018},
volume = {10},
number = {1},
pages = {84--92},
doi = {10.1111/luts.12144}
}
EUVIMED